搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
13 小时
Lantern Pharma获得FDA三项罕见病认定
DALLAS - 利用人工智能(AI)进行癌症药物开发的生物制药公司Lantern Pharma Inc. (NASDAQ:LTRN)宣布,其研究性药物LP-184获得美国食品和药物管理局(FDA)三项罕见儿科疾病认定(RPDD)。这些认定涵盖恶性横纹肌样瘤(MRT)、横纹肌肉瘤(RMS)和肝母细胞瘤,此前该药物已获得非典型畸胎样横纹肌样瘤(ATRT)的RPDD认定。 RPDD认定授予用于治疗美国 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Left note, bail denied
1951 kidnap victim found
Didn't authorize apology
Daylight saving time
Robinson loses key staff
Colo. shooter found guilty
Makes emergency landing
Closing last full-size store
Astronauts return to Earth
San Francisco homelessness
California sues ExxonMobil
Makes new offer to union
More troops to Middle East
Returning Indian antiquities
Reds fire manager
Bulls escape MA rodeo
Dolphins legend Morris dies
Co-founder testifies
NE electoral change blocked
FBI: Violent crime declined
Visits US ammunition plant
Tech ban proposed
Gulf Coast storm warning
SpaceX plans Mars missions
To meet Vietnamese pres
No govt. shutdown for now
No. 1 at box office again
Iran coal mine blast
Economic speech this week
Donlon's homes searched
反馈